Back

New guidelines: Importance to reduce LDL-C in patients at risk.

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Add on to take back control: Combining lipid lowering therapies for the management of high risk patients Drug therapy Open Access ESC Congress 2020

About the speaker

Photo
Professor Lluis Masana

University Hospital Sant Joan de Reus, Reus (Spain)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor J. Chapman (Paris, FR) Professor L. Tokgozoglu (Ankara, TR)
Video
Presentation thumbnail
The role of add-on therapies in the management of high and very high CV risk patients.
Professor P. Perrone-Filardi (Naples, IT)
Video
Presentation thumbnail
Novel options for the combination of LDL-C lowering therapies.
Professor K. Ray (London, GB)
Video
Presentation thumbnail
Live Q & A with chairmen & speakers.
Professor L. Tokgozoglu (Ankara, TR) Professor J. Chapman (Paris, FR)
Video

Access the full session

Session thumbnail
Add on to take back control: Combining lipid lowering therapies for the management of high risk patients
Video

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
What’s new in LDL lowering?
thumbnail
Congress Presentation
Stepwise approach to lipid-lowering therapies: which one, when, and for whom?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources